Navigation Links
Innocoll Announces Dosing of First Patient in Second US Phase 3 Clinical Trial to Investigate CollaRx(R) GENTAMICIN SURGICAL IMPLANT for the Prevention of Surgical Site Infections
Date:2/19/2008

ASHBURN, Va., Feb. 19 /PRNewswire/ -- Innocoll, Inc., a privately-held specialty pharmaceutical company, announced that the second of two phase 3 clinical trials sponsored by its wholly owned subsidiary, Innocoll Technologies Ltd, to investigate CollaRx(R) GENTAMICIN SURGICAL IMPLANT for the prevention of surgical site infections, has commenced dosing.

GENTAMICIN SURGICAL IMPLANT is a fully biodegradable, leave-behind surgical implant impregnated with the broad spectrum aminoglycoside antibiotic, gentamicin. It is designed to provide a high concentration of gentamicin (which has a concentration-dependent mechanism of action) directly to the target tissue for localized action, while maintaining low systemic levels well below the toxicity threshold. The product was developed using Innocoll's proprietary collagen-based drug delivery technology, CollaRx, and (outside of the US) is indicated as an adjunct to systemic antibiotic therapy for the treatment of localized, deep tissue infections and the prevention of surgical site infections in both hard and soft tissues. GENTAMICIN SURGICAL IMPLANT is already approved in 49 countries spanning Europe, Latin America, Middle East, Africa and Asia and there are more than 60 prospective clinical trials and published case reports totaling over 7,500 patients documenting its safety and efficacy over a broad range of orthopedic, colorectal, cardiothoracic, vascular, and neurosurgical procedures.

According to advice from FDA received at both pre-IND and post-IND meetings held in 2007, Innocoll will conduct two multi-centered phase 3 clinical trials in the US to support the planned New Drug Application (NDA). The first trial in cardiac surgery patients at higher risk of surgical site infection commenced in December 2007. The second trial, which has now enrolled its first patient, is in general surgery patients undergoing open colorectal surgery. Innocoll has appointed Duke University's Duke Clinical Research Instit
'/>"/>

SOURCE Innocoll, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Innocoll Announces Dosing of First Patient in US Phase 2 Clinical Trial to Investigate CollaRx(R) BUPIVACAINE SURGICAL IMPLANT for the Management of Post-operative Pain
2. Innocoll Announces Dosing of First Patient in US Phase 3 Clinical Trial to Investigate CollaRx(R) GENTAMICIN SURGICAL IMPLANT for the Prevention of Surgical Site Infections in Cardiac Surgery Patients
3. Innocoll Announces Dosing of First Patient in US Phase 2 Clinical Trial to Investigate CollaRx(R) GENTAMICIN TOPICAL for the Treatment of Mildly Infected Diabetic Foot Ulcers
4. Innocoll Provides a Progress Update on its Clinical Development Programs and Specialty Pharmaceutical Operations
5. Advanced Life Sciences Announces Successful Thorough QT Study of Cethromycin
6. Poniard Pharmaceuticals Announces Positive First-line Phase 1 Safety and Efficacy Data With Picoplatin in Metastatic Prostate Cancer Patients
7. TorreyPines Therapeutics Announces Strategic Plan with Focus on Clinical Development Activities to Maximize Value of Versatile Lead Compounds
8. Raven Announces Completion of Enrollment in the Phase 1/2a Clinical Trial of RAV12 Therapeutic Antibody for the Treatment of Adenocarcinomas
9. Watson Announces Silodosin NDA Accepted for Filing by FDA for the Treatment of Benign Prostatic Hyperplasia
10. Micromet Announces the Publication of BiTE Antibody Review in Drugs of the Future
11. Pharmacyclics Announces Data and Publication Characterizing Highly-Selective HDAC Inhibitor
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... 2014 Research and Markets has ... Trend Forecast of Pharmaceutical Equipment Market in China, 2014-2018" ... and Development Trend Forecast of Pharmaceutical Equipment Market in ... China,s pharmaceutical equipment industry in the ... landscape, and business performance of domestic major enterprises, as ...
(Date:8/29/2014)... , Aug. 29, 2014  Unilife Corporation ("Unilife" ... announced today that it intends to release its financial ... ended June 30, 2014 after market trading ends on ... scheduled a conference call for 4:30 p.m. U.S. EDT ... at 6:30 a.m. AEST), to review the Company,s financial results, ...
(Date:8/29/2014)... Aug. 29, 2014  Pacific Medical Data Solutions is ... website design . The main website, along with the ... company,s new services and content relevant to the medical ... streamlined design, viewers can now better understand how PMDS ... practices and create a more visible platform about medical ...
Breaking Medicine Technology:Research and Development Trend Forecast of Pharmaceutical Equipment Market in China, 2014-2018 2Unilife Corporation to Announce Financial Results for Fiscal Year 2014 Fourth Quarter and Year End on Tuesday, September 9, 2014 2PMDS Announces New Website 2
... Preliminary results,were released today from a late-stage clinical ... study did not meet its primary or secondary,endpoints of ... people with moderate disease., The findings are initial ... known as the EXPLORER study. Rituxan is approved by ...
... 29 Medarex, Inc.,(Nasdaq: MEDX ) announced today ... melanoma, prostate cancer and other cancers, as,well as for ... to be the subject of presentations at the Annual,Meeting ... May,30-June 3, 2008 in Chicago:, Survival, Response, ...
Cached Medicine Technology:Statement From the Lupus Foundation of America Regarding the Release of Top-Line Results From a Study of Rituxan for the Treatment of Lupus 2Medarex Announces Presentations at Annual Meeting of the American Society of Clinical Oncology 2Medarex Announces Presentations at Annual Meeting of the American Society of Clinical Oncology 3Medarex Announces Presentations at Annual Meeting of the American Society of Clinical Oncology 4
(Date:8/31/2014)... An analysis of 32 studies compiled by University ... between lower levels of Vitamin D and a higher ... 2014 issue of American Journal of Public Health, ... D found in blood. , Researchers found that ... 9 nanograms/milliliter (ng/mL) were twice as likely to die ...
(Date:8/31/2014)... MedixSafe has become very popular in the ... narcotics lockers . Electronic Security Specialists has ... worldwide. “We have now shipped multiple orders to Canada ... Manager , MedixSafe is a division of Electronic Security ... company with over 30 years in the security arena. ...
(Date:8/31/2014)... (PRWEB) August 31, 2014 Just in time ... serving up only wild, sustainable Alaska Salmon, award winning ... at the Duke's Green Lake location , Sunday, September ... expect to sample several ethnic salmon BBQ culinary delights. Live ... Salmon recipes from Hawaii, Puerto Rico and Mexico will be ...
(Date:8/31/2014)... Recently, BambooIndustry.com, one of the most popular suppliers of bamboo ... bamboo veneers . Additionally, it has deiced offer autumn ... quality products. The promotion will last from today until September ... top quality veneers are hot in the global market. “We ... veneers. All these items are made according to our latest ...
(Date:8/31/2014)... AZ (PRWEB) August 31, 2014 Stuart ... Mesa, Arizona, prescribes sublingual immunotherapy to help his ... tree nut allergies. Dr. Agren said that it has ... foods and, in many cases, restored peace of mind. ... lead to a host of symptoms, including rashes, digestive ...
Breaking Medicine News(10 mins):Health News:NutriGold Highlights New Study on the Importance of Vitamin D to Our Life Span 2Health News:NutriGold Highlights New Study on the Importance of Vitamin D to Our Life Span 3Health News:NutriGold Highlights New Study on the Importance of Vitamin D to Our Life Span 4Health News:Memphis-based Electronic Security Specialists Now Offers MedixSafe Narcotics Cabinets Internationally 2Health News:Memphis-based Electronic Security Specialists Now Offers MedixSafe Narcotics Cabinets Internationally 3Health News:Seattle Seafood Restaurant Duke's Chowder House on Green Lake Will Celebrate The Long Anticipated Indian Summer With First Annual Sizzling BBQ Salmon Tasting Event. 2Health News:High Quality Bamboo Veneers from Bambooindustry.com Receive International Attention 2Health News:Family Allergy Clinic Announces Q4 2014 Release of Oral Drops for Tree Nut Allergies 2Health News:Family Allergy Clinic Announces Q4 2014 Release of Oral Drops for Tree Nut Allergies 3
... WASHINGTON, May 15 A new report, funded and ... 1,500 drug codes from its,CY 2008 Part D Formulary ... these drugs from their Medicare offerings in 2008,resulting in ... The CMS action was driven in part to remove ...
... Men Employees Hold Large Companies to a Higher Standard with ... Mandatory Healthcare ... women (58%) were more likely than men (47%) to find paying,for healthcare ... likely than men (42%) to have done some retirement,healthcare planning., Gender ...
... identified hundreds of genes involved in the development of cancer ... find the cancer causing mutations. , The study found ... 350 regions in the mouse genome in cancer formation. 50 ... in human cancers while the other regions were novel, adding ...
... to Raise Money for HIV ... Services in Tri-State Area, NEW YORK, May 15 Duane ... donate $50,000 as,a Grand-level sponsor of AIDS Walk New York, which ... programs and,services in the tri-state area. Since 1986, the annual walk ...
... real-world problems ... in radiology, BOSTON, May ... medical image and information management solutions,today announced that its complete suite of ... 2008,Annual Meeting in Seattle, WA, from May 15 to 18. AMICAS will ...
... Vendormate, Inc., the leading provider,of business-credentialing ... from risky vendors, completes its tenure at,Georgia ... ATDC is a,nationally-recognized science and technology incubator ... companies., ATDC provides strategic business advice ...
Cached Medicine News:Health News:Avalere Report Shows Unapproved Prescription Drugs Dropped from CMS Formulary Reference File 2Health News:Avalere Report Shows Unapproved Prescription Drugs Dropped from CMS Formulary Reference File 3Health News:Avalere Report Shows Unapproved Prescription Drugs Dropped from CMS Formulary Reference File 4Health News:Guardian Survey: Employees Are Confused About Their Health Coverage and Have No Plans for Healthcare in Retirement 2Health News:Guardian Survey: Employees Are Confused About Their Health Coverage and Have No Plans for Healthcare in Retirement 3Health News:Guardian Survey: Employees Are Confused About Their Health Coverage and Have No Plans for Healthcare in Retirement 4Health News:Guardian Survey: Employees Are Confused About Their Health Coverage and Have No Plans for Healthcare in Retirement 5Health News:Connecting cancer genes 2Health News:Duane Reade Announces Proud Sponsorship of AIDS Walk New York 2Health News:AMICAS Focuses on the Future of Radiology IT at SIIM 2008 2Health News:AMICAS Focuses on the Future of Radiology IT at SIIM 2008 3Health News:Vendormate Graduates ATDC Technology Incubator Program 2
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: